Results 111 to 120 of about 424,800 (170)

Avoiding methodological bias in studies of amyloid imaging results disclosure

Alzheimer’s Research & Therapy, 2019
Carl Taswell, Cheryl Donohue, Maree T. Mastwyk, Andrea G. Louey, Jacqueline Giummarra, Joanne Robertson, David G. Darby, Colin L. Masters, Christopher C. Rowe   +8 more
doaj   +1 more source

Comparing and combining TSPO-PET tracers in tauopathies. [PDF]

Eur J Nucl Med Mol Imaging
Crook H, Franzmeier N, Rahmouni N, Gnörich JS, Fryer TD, Hong YT, Roemer-Cassiano SN, Palleis C, Strauss A, Jones PS, Aigbirhio FI, Hopewell R, Rauchmann BS, Massarweh G, Perneczky R, Levin J, Höglinger GU, Rowe JB, O'Brien JT, Rosa-Neto P, Brendel M, Malpetti M.   +21 more
europepmc   +1 more source

Amyloid accumulation, brain atrophy, and cognitive decline in emergent Alzheimer's disease. [PDF]

Alzheimers Dement (Amst)
Xia Y, Bourgeat P, Doré V, Fripp J, Lim YY, Laws SM, Fowler C, Rowe CC, Masters CL, Coulson EJ, Maruff P, AIBL Research Group.   +11 more
europepmc   +1 more source

A computational model to describe multi-regional brain architecture during neurodegeneration in Alzheimer's disease. [PDF]

Sci Rep
Li X, Rockall AG, Edison P, Alzheimer’s Disease Neuroimaging Initiative (ADNI), Australian Imaging Biomarkers and Lifestyle (AIBL) Study, Aboagye EO.   +5 more
europepmc   +1 more source